BUSINESS● LOW1h ago · Oct 26, 2026, 11:04 AM
Acumen Pharmaceuticals GAAP EPS of -$0.35 beats by $0.02
Seeking Alpha Tech · global
Acumen Pharmaceuticals reported GAAP Earnings Per Share (EPS) of -$0.35, which exceeded expectations by $0.02. This indicates a minor positive surprise in their financial performance.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowOil: who between Senegal and Côte d'Ivoire will win the investment race?Jeune AfriqueBUSINESS12m agoAST SpaceMobile secures Brazil spectrum, adds four mobile partnersSeeking Alpha Tech